Supplementary Legends from A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks vFLIP K13-Induced NF-κB

MLA

Preet M. Chaudhary, et al. Supplementary Legends from A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks VFLIP K13-Induced NF-ΚB. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22451855.v1.

APA

Preet M. Chaudhary, Hittu Matta, & Ramakrishnan Gopalakrishnan. (2023). Supplementary Legends from A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks vFLIP K13-Induced NF-κB. https://doi.org/10.1158/1078-0432.22451855.v1

Chicago

Preet M. Chaudhary, Hittu Matta, and Ramakrishnan Gopalakrishnan. 2023. “Supplementary Legends from A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks VFLIP K13-Induced NF-ΚB,” March. doi:10.1158/1078-0432.22451855.v1.